Xiong Y - Search Results

1

Validation of novel grading schemes and refinement of the Leibovich risk groups for chromophobe renal cell carcinoma.

Lin H, Wang C, Zhao Y, Wang R, Xi W, Xiong Y, Xiao L, Liu Y, Zhang S, Dai C. Lin H, et al. Among authors: xiong y. World J Urol. 2024 Dec 23;43(1):45. doi: 10.1007/s00345-024-05394-3. World J Urol. 2024. PMID: 39714606

2

Prognostic Value of SETD2 Expression in Patients with Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors.

Wang J, Liu L, Qu Y, Xi W, Xia Y, Bai Q, Xiong Y, Long Q, Xu J, Guo J. Wang J, et al. Among authors: xiong y. J Urol. 2016 Nov;196(5):1363-1370. doi: 10.1016/j.juro.2016.06.010. Epub 2016 Jun 8. J Urol. 2016. PMID: 27288695

3

Evaluation of Tumor Pseudocapsule Status and its Prognostic Significance in Renal Cell Carcinoma.

Xi W, Wang J, Liu L, Xiong Y, Qu Y, Lin Z, Chen X, Wang Z, Xu J, Guo J. Xi W, et al. Among authors: xiong y. J Urol. 2018 Apr;199(4):915-920. doi: 10.1016/j.juro.2017.10.043. Epub 2017 Nov 8. J Urol. 2018. PMID: 29128576

4

Comparison and validation of different risk models for papillary renal cell carcinoma.

Lin H, Sun Q, Li Z, Zheng J, Zhang X, Xiong Y, Chen H, Hou Y, Xi W, Lin J. Lin H, et al. Among authors: xiong y. Urol Oncol. 2023 Aug;41(8):358.e1-358.e7. doi: 10.1016/j.urolonc.2023.05.017. Epub 2023 Jun 30. Urol Oncol. 2023. PMID: 37394414

5

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma.

Xia Y, Liu L, Xiong Y, Bai Q, Wang J, Xi W, Qu Y, Xu J, Guo J. Xia Y, et al. Among authors: xiong y. Cancer Sci. 2016 Sep;107(9):1243-9. doi: 10.1111/cas.13007. Epub 2016 Sep 1. Cancer Sci. 2016. PMID: 27389969 Free PMC article.

6

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma.

Xiong Y, Liu L, Xia Y, Wang J, Xi W, Bai Q, Qu Y, Long Q, Xu J, Guo J. Xiong Y, et al. Oncotarget. 2016 Sep 27;7(39):63661-63668. doi: 10.18632/oncotarget.11606. Oncotarget. 2016. PMID: 27564117 Free PMC article.

7

Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma.

Xia Y, Liu L, Bai Q, Wang J, Xi W, Qu Y, Xiong Y, Long Q, Xu J, Guo J. Xia Y, et al. Among authors: xiong y. Sci Rep. 2016 Sep 7;6:32657. doi: 10.1038/srep32657. Sci Rep. 2016. PMID: 27600310 Free PMC article.

8

Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma.

Qu Y, Liu L, Wang J, Xi W, Xia Y, Bai Q, Xiong Y, Long Q, Xu J, Guo J. Qu Y, et al. Among authors: xiong y. Oncotarget. 2016 Dec 20;7(51):84775-84784. doi: 10.18632/oncotarget.12476. Oncotarget. 2016. PMID: 27713173 Free PMC article.

9

Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.

Xiong Y, Liu L, Wang J, Xi W, Xia Y, Bai Q, Qu Y, Long Q, Xu J, Guo J. Xiong Y, et al. Oncotarget. 2017 Apr 11;8(15):25650-25659. doi: 10.18632/oncotarget.12827. Oncotarget. 2017. PMID: 27783999 Free PMC article.

10

Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma.

Xi W, Liu L, Wang J, Xia Y, Bai Q, Xiong Y, Qu Y, Long Q, Xu J, Guo J. Xi W, et al. Among authors: xiong y. Oncotarget. 2016 Dec 6;7(49):80925-80934. doi: 10.18632/oncotarget.13108. Oncotarget. 2016. PMID: 27821813 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11,253 results

Search Page

Filters